Patents by Inventor Jodi P. Gurney
Jodi P. Gurney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11090339Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).Type: GrantFiled: August 5, 2019Date of Patent: August 17, 2021Assignee: Celularity Inc.Inventors: Uri Herzberg, Jodi P. Gurney, Robert J. Hariri
-
Publication number: 20200023015Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).Type: ApplicationFiled: August 5, 2019Publication date: January 23, 2020Applicant: CELULARITY, INC.Inventors: Uri Herzberg, Jodi P. Gurney
-
Publication number: 20190117705Abstract: Provided herein are compositions comprising mononuclear cells from human placental perfusate and methods of using such cells, including using the cells together with hematopoietic cells, for example to establish chimerism, reduce the severity or duration of graft versus host disease, treat or ameliorate symptoms of sarcopenia, metabolic disorders and hematologic disorders, such as hematologic malignancies, and treat or ameliorate symptoms of ischemic encephalopathy (e.g., hypoxic ischemic encephalopathy) and other central nervous system injuries.Type: ApplicationFiled: November 23, 2018Publication date: April 25, 2019Applicant: CELULARITY, INC.Inventors: Jodi P. Gurney, Xiaokui Zhang, Stacy Herb, Robert J. Hariri
-
Patent number: 10179152Abstract: Provided herein are methods of treatment comprising administering to a subject, e.g., a human subject, mononuclear cells from human placental perfusate and hematopoietic cells, and compositions comprising them, and their uses to establish chimerism, engraft tissue (e.g., blood), reduce the severity or duration of graft versus host disease, and treat or ameliorate symptoms of metabolic disorders and hematologic disorders, such as hematologic malignancies.Type: GrantFiled: October 2, 2014Date of Patent: January 15, 2019Assignee: Celularity, Inc.Inventors: Jodi P. Gurney, Xiaokui Zhang, Stacy Herb, Robert J. Hariri
-
Publication number: 20180133261Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).Type: ApplicationFiled: November 1, 2017Publication date: May 17, 2018Applicant: Anthrogenesis CorporationInventors: Uri Herzberg, Jodi P. Gurney
-
Patent number: 9925221Abstract: Provided herein are methods of treatment of an individual having amyotrophic lateral sclerosis, comprising administering to the individual a therapeutically effective amount of placental stem cells, e.g., tissue culture surface-adherent placental stem cells (PDACs). In one aspect, provided herein is a method of treating amyotrophic lateral sclerosis (ALS) comprising administering to an individual having ALS a therapeutically effective amount of placental stem cells. In certain embodiments, “therapeutically effective” means an amount effective to reduce or ameliorate one or more symptoms of ALS.Type: GrantFiled: September 10, 2012Date of Patent: March 27, 2018Assignee: Celularity, Inc.Inventors: Robert J. Hariri, Jodi P. Gurney
-
Publication number: 20170042944Abstract: Provided herein are compositions and methods for treating one or more disorders or conditions in infants, including premature infants, by administering to such infants umbilical cord blood or cells obtained from umbilical cord blood and, optionally, cells obtained from placental perfusate, placental stem cells and/or blood additives. Also provided herein are methods for treating one or more disorders or conditions in infants, including premature infants, by administering to such infants cells obtained from placental perfusate alone or placental stem cells alone or in combination with umbilical cord blood or cells obtained from umbilical cord blood.Type: ApplicationFiled: April 20, 2015Publication date: February 16, 2017Applicant: ANTHROGENESIS CORPORATIONInventors: Robert J. HARIRI, Jodi P. GURNEY, Xiaokui ZHANG, Stacy Herb, Cindy HARTUNG
-
Publication number: 20160279171Abstract: Provided herein are compositions comprising mononuclear cells from human placental perfusate and methods of using such cells, including using the cells together with hematopoietic cells, for example to establish chimerism, reduce the severity or duration of graft versus host disease, treat or ameliorate symptoms of sarcopenia, metabolic disorders and hematologic disorders, such as hematologic malignancies, and treat or ameliorate symptoms of ischemic encephalopathy (e.g., hypoxic ischemic encephalopathy) and other central nervous system injuries.Type: ApplicationFiled: November 14, 2014Publication date: September 29, 2016Applicant: Anthrogenesis CorporationInventors: Jodi P. Gurney, Xiaokui Zhang, Stacy Herb, Robert J. Hariri
-
Publication number: 20160235790Abstract: Provided herein are methods of treatment comprising administering to a subject, e.g., a human subject, mononuclear cells from human placental perfusate and hematopoietic cells, and compositions comprising them, and their uses to establish chimerism, engraft tissue (e.g., blood), reduce the severity or duration of graft versus host disease, and treat or ameliorate symptoms of metabolic disorders and hematologic disorders, such as hematologic malignancies.Type: ApplicationFiled: October 2, 2014Publication date: August 18, 2016Applicant: Anthrogenesis CorporationInventors: Jodi P. GURNEY, Xiaokui ZHANG, Stacy HERB, Robert J. HARIRI
-
Publication number: 20160166618Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent amnion-derived cells (AMDACs). Because mammalian placentas are plentiful and are normally discarded as medical waste, they represent a unique source of medically-useful stem cells.Type: ApplicationFiled: October 18, 2013Publication date: June 16, 2016Applicant: ANTHROGENESIS CORPROATIONInventors: Uri Herzberg, Robert J. Hariri, Jodi P Gurney
-
Publication number: 20160074439Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).Type: ApplicationFiled: November 25, 2015Publication date: March 17, 2016Applicant: ANTHROGENESIS CORPORATIONInventors: Uri Herzberg, Jodi P. Gurney
-
Publication number: 20150313947Abstract: Provided herein are methods of treatment of individuals having schizophrenia, or schizophreniform disorder, using angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of and compositions comprising, such cells. A need exists for therapies that can ameliorate or palliate schizophrenia, or a schizophreniform disorder, or symptoms of the same. Provided herein are methods of treating individuals who have schizophrenia, or schizophreniform disorder, comprising administration of therapeutically-effective amounts (numbers) of AMDACs.Type: ApplicationFiled: December 2, 2013Publication date: November 5, 2015Inventors: Robert J. Hariri, Jodi P. Gurney
-
Publication number: 20150313948Abstract: Provided herein are uses of compositions comprising extracellular matrix (ECM) and compositions comprising ECM components in the treatment of non-dental oral lesions.Type: ApplicationFiled: December 6, 2013Publication date: November 5, 2015Applicant: ANTHROGENESIS CORPORATIONInventors: Robert J. Hariri, Jodi P. Gurney, Mohit B. Bhatia, Wolfgang Hofgartner
-
Publication number: 20150224148Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).Type: ApplicationFiled: April 21, 2015Publication date: August 13, 2015Applicant: ANTHROGENESIS CORPORATIONInventors: Uri Herzberg, Jodi P. Gurney
-
Patent number: 9040035Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).Type: GrantFiled: May 31, 2012Date of Patent: May 26, 2015Assignee: ANTHROGENESIS CORPORATIONInventors: Uri Herzberg, Jodi P. Gurney
-
Publication number: 20150044177Abstract: Provided herein are methods of treatment of an individual having amyotrophic lateral sclerosis, comprising administering to the individual a therapeutically effective amount of placental stem cells, e.g., tissue culture surface-adherent placental stem cells (PDACs). In one aspect, provided herein is a method of treating amyotrophic lateral sclerosis (ALS) comprising administering to an individual having ALS a therapeutically effective amount of placental stem cells. In certain embodiments, “therapeutically effective” means an amount effective to reduce or ameliorate one or more symptoms of ALS.Type: ApplicationFiled: September 10, 2012Publication date: February 12, 2015Applicant: ANTHROGENESIS CORPORATIONInventors: Robert J. Hariri, Jodi P. Gurney
-
Publication number: 20120328583Abstract: Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).Type: ApplicationFiled: May 31, 2012Publication date: December 27, 2012Applicant: Anthrogenesis CorporationInventors: Uri Herzberg, Jodi P. Gurney